Q&A: Kip Ludwig on bioelectronic medicine
By hacking the nervous system with minimally invasive, super-precise techniques, Associate Professor of Neurological Surgery Kip Ludwig and his team are creating new treatments to relieve pain and restore function for those suffering from diseases and conditions as diverse as migraine, hypertension and cancer. This field of study is called neuromodulation, and its advances may render orally administered drugs obsolete.
New Initiative for Theranostics and Particle Therapy launched
A key focus of the initiative will be translational research, or research that is designed to benefit human health. Investigators will assess how particle beam radiation may be effective to treat cancers that are difficult to treat using conventional radiation therapy, how diagnostic and treatment steps can be combined into a single step referred to as theranostics, and how radiation treatment plans can be personalized for each patient.
New study supports recommendation to begin mammogram screening at 40
Breast cancer screening every two years beginning at age 40 has the potential to reduce the number of women who die of breast cancer while minimizing the harms, according to a large study published today.
Partnerships Bolster Biotechnology Research and Training
In October 2023, President Joe Biden announced Wisconsin’s selection among 31 Regional Technology Hubs designated by the Economic Development Administration under the 2021 Creating Helpful Incentives to Produce Semiconductors (CHIPS) and Science Act.
Stem cells’ light signatures improve understanding of aging in the brain
Midlife testing may help predict later cognitive impairment
When researchers test motor skills, hearing, vision and smell in people in their midlife, they are better able to identify those who may develop cognitive decline or impairment 10 years later, according to a new study by researchers at the University of Wisconsin School of Medicine and Public Health.
Air sampling at schools accurately detects flu and COVID-19 virus levels
Air samplers placed in school cafeterias provided an accurate look at a flu epidemic and at constant low levels of COVID-19 infections in a K-12 school district during the 2022-23 school year, according to a new study from researchers at the University of Wisconsin School of Medicine and Public Health.
Gut inflammation linked to aging and Alzheimer’s disease
A new study by researchers at the University of Wisconsin School of Medicine and Public Health suggests a link between gut inflammation and changes in the brain and declines in memory, further supporting a connection between the gut and brain in Alzheimer’s disease.
UW–Madison receives $150 million grant to lead nationwide Alzheimer’s disease study
The University of Wisconsin School of Medicine and Public Health has been awarded funding from the National Institutes of Health for a nationwide research initiative to investigate the neurobiology of Alzheimer’s disease and related dementias.
UW clinical trial tests new way to treat glioblastoma
A new clinical trial at UW Health | Carbone Cancer Center uses a personalized medicine method to try to teach the immune system to recognize and destroy glioblastoma tumors.
UW researcher’s career inspired by his own spinal cord injury
Dan Hellenbrand grew up on a small farm near Lodi and by his 20s was on the path to his desired career in carpentry. Then, in an instant, that path vanished.
Researchers pursue easier, earlier detection of Alzheimer’s disease in Black adults
A blood biomarker and a method of testing cognitive processes such as memory and thinking could hold promise for identifying middle-aged Black people who are at risk for later developing Alzheimer’s disease, according to a new study from the University of Wisconsin School of Medicine and Public Health.